{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 384087896
| IUPAC_name = 5-Ethyl-8-oxo-5,8-dihydro[1,3]dioxolo[4,5-''g'']quinoline- 7-carboxylic acid
| image = Oxolinic acid.png
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|oxolinic-acid}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 14698-29-4
| ATC_prefix = J01
| ATC_suffix = MB05
| PubChem = 4628
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = L0A22B22FT
| KEGG_Ref = {{keggcite|changed|kegg}}
| KEGG = D02301
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 416755
| ChEBI_Ref = {{ebicite|changed|EBI}} 
| ChEBI = 138856
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 4467

<!--Chemical data-->
| C=13 | H=11 | N=1 | O=5
| molecular_weight = 261.23 g/mol
| smiles            = CCN1C=C(C(=O)C2=CC3=C(C=C21)OCO3)C(=O)O
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI          = 1S/C13H11NO5/c1-2-14-5-8(13(16)17)12(15)7-3-10-11(4-9(7)14)19-6-18-10/h3-5H,2,6H2,1H3,(H,16,17)
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey       = KYGZCKSPAKDVKC-UHFFFAOYSA-N
}}

'''Oxolinic acid''' is a [[Quinolone antibiotic|quinolone]] [[antibiotic]] developed in Japan in the 1970s.<ref>JP Patent 49138244</ref><ref name="pmid384788">{{cite journal |vauthors=Gleckman R, Alvarez S, Joubert DW, Matthews SJ |title=Drug therapy reviews: oxolinic acid |journal=American Journal of Hospital Pharmacy |volume=36 |issue=8 |pages=1077–9 |date=August 1979 |pmid=384788 |doi= |url= }}</ref> Dosages 12–20&nbsp;mg/kg orally administered for five to ten days.  The antibiotic works by inhibiting the enzyme [[DNA gyrase]]. It also acts as a [[dopamine reuptake inhibitor]] and has stimulant effects in mice.<ref name="pmid9928913">{{cite journal |vauthors=Garcia de Mateos-Verchere J, Vaugeois JM, Naudin B, Costentin J |title=Behavioural and neurochemical evidence that the antimicrobial agent oxolinic acid is a dopamine uptake inhibitor |journal=European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology |volume=8 |issue=4 |pages=255–9 |date=December 1998 |pmid=9928913 |doi= 10.1016/S0924-977X(97)00083-7|url=http://linkinghub.elsevier.com/retrieve/pii/S0924-977X(97)00083-7}}</ref>

==See also==
* [[Amfonelic acid]]
* [[Fluoroquinolone]]

==References==
{{reflist}}

{{QuinoloneAntiBiotics}}
{{Dopaminergics}}

{{Authority control}}

[[Category:Quinolone antibiotics]]
[[Category:Dopamine reuptake inhibitors]]
[[Category:Carboxylic acids]]
[[Category:Nitrogen heterocycles]]
[[Category:Oxygen heterocycles]]
[[Category:Heterocyclic compounds (3 rings)]]


{{antibiotic-stub}}